Table 3.
Correlation between estrogen receptor (ER)β and clinicopathologic parameters in patients with pancreatic neuroendocrine tumors
| Characteristics (%) | ERβ Category | p value | ||
|---|---|---|---|---|
| Negative (n=5) | Low (n=87) | High (n=39) | ||
| Median age (range) | 56 y (49–63) | 54 y (22–79) | 60 y (18–76) | 0.41 |
| Median size (range) | 5.0 cm (2.0 – 8.0) | 4.0 cm (1.1 – 15.0) | 2.6 (0.7 – 20.0) | 0.02 |
| Functionality | 0.23 | |||
| Non-functional | 4 (4) | 76 (70) | 29 (26) | |
| Insulinoma | 0 (0) | 7 (50) | 7 (50) | |
| Non-insulinoma | 1 (13) | 4 (50) | 3 (37) | |
| MEN1 | 1 (9) | 5 (45) | 5 (45) | 0.26 |
| WHO grade | 0.02 | |||
| Low (G1) | 5 (7) | 41 (57) | 26 (36) | |
| Intermediate (G2) | 0 (0) | 46 (78) | 13 (22) | |
| AJCC Stage | 0.006 | |||
| I-IIA | 1 (2) | 34 (55) | 26 (43) | |
| IIB | 3 (9) | 21 (64) | 9 (27) | |
| IV | 1 (3) | 32 (86) | 4 (11) | |
Abbreviations: WHO, World Health Organization; AJCC, American Joint Committee on Cancer